Marinus’ clinical trial of ganaxolone fails to meet primary endpoint
In response to the findings, Marinus is halting further clinical development of ganaxolone.
Services - Clinical Trials
Clinical Trial Services & Solutions for the Clinical Trials Industry
Charting the road to operational success in clinical trials
MyMD to begin Phase II trial of rheumatoid arthritis therapy
Medicure approved to enrol patients in paediatric disease trial
Immutep expands sites for INSIGHT-003 NSCLC therapy study
Chengdu Origen and Vanotech dose first subject in wet AMD therapy trial
SciSparc commences Tourette Syndrome therapy trial
